CIA
MIRM icon

Concurrent Investment Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Concurrent Investment Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Hold
3,964
– – ﹤0.01% 1448
2026
Q1 		$366K Buy
3,964
+964
+32% +$90.7K ﹤0.01% 1379
2025
Q4 		$237K Hold
3,000
– – ﹤0.01% 1546
2025
Q3 		$220K Buy
+3,000
New +$191K ﹤0.01% 1304

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Concurrent Investment Advisors's MIRM Position: Q2 2026 in Review

Concurrent Investment Advisors held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 3,964 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Concurrent Investment Advisors first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Concurrent Investment Advisors held 3,964 shares of Mirum Pharmaceuticals worth $464K as of Q2 2026.
  • Concurrent Investment Advisors left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1448 holding.
  • Concurrent Investment Advisors first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.